Advertisement

Theories of Tolerance to and Physical Dependence on Opioids

  • Abraham Wikler

Abstract

Though under certain conditions (see below), tolerance to opioids can develop without concomitant physical dependence, the two phenomena will be considered together inasmuch as most explanatory theories postulate common mechanisms and assume that one sort or another of “counteradaptation” to the agonistic actions of opioids develops during repeated drug administration (accounting for tolerance); this results in “latent hyperexcitability” of the central nervous system, which is suppressed as long as opioids are administered; when opioids are abruptly withdrawn, or when a narcotic antagonist is administered, the latent hyperexcitability becomes manifest as the opioid-abstinence syndrome (indicative of physical dependence).

Keywords

Physical Dependence Morphine Withdrawal Morphine Injection Morphine Tolerance Cold Plate 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Adams, W. J., Yeh, S. Y., Woods, A., and Mitchell, C. L., 1969, Drug-test interaction as a factor in the development of tolerance to the analgesic effect of morphine, J. Pharmacol. Exp. Ther. 168: 251–257.PubMedGoogle Scholar
  2. Axelrod, J., 1956a, The enzymatic N-demethylation of narcotic drugs, J. Pharmacol. Exp. Ther. 117: 322–330.PubMedGoogle Scholar
  3. Axelrod, J., 1956b, Possible mechanism of tolerance to narcotic drugs, Science 124: 263–264.PubMedCrossRefGoogle Scholar
  4. Bergel, F., 1951, Parasympathomimetics and anticholinesterases, J. Pharmacol. 3: 385–399.CrossRefGoogle Scholar
  5. Carlsson, A., and Lindqvist, M., 1963, Effect of chlorpromazine or haloperidol on forma-tion of 3-methoxytryramine and normetanephrine in mouse brain, Acta Pharmacol. Toxicol. 20: 140–144.CrossRefGoogle Scholar
  6. Clouet, D. H., and Ratner, M., 1970, Catecholamine biosynthesis in brains of rats treated with morphine, Science 168: 854–856.PubMedCrossRefGoogle Scholar
  7. Cochin, J., 1971, Role of possible immune mechanisms in the development of tolerance, in Narcotic Drugs: Biochemical Pharmacology ( D. H. Clouet, Ed.), pp. 432–448. Plenum Press, New York.Google Scholar
  8. Cochin, J., and Kornetsky, C., 1964, Development and loss of tolerance to morphine in the rat after single and multiple injections, J. Phaanacol. Exp. Ther. 145: 1–10.Google Scholar
  9. Cochin, J., and Kornetsky, C., 1968, Factors in blood of morphine-tolerant animals that attenuate or enhance effects of morphine in nontolerant animals, in The Addictive States: Research Publications of the Association for Research in Nervous and Mental Disease, Vol. 46 ( A. Wikler, Ed.), pp. 263–269 Williams & Wilkins, Baltimore, Maryland.Google Scholar
  10. Cochin, J., and Mushlin, B. E., 1970, The role of dose-interval in the development of tolerance to morphine, Fed. Proc. 29: 685.Google Scholar
  11. Cohen, M., Keats, A. S., Kirvoy, W., and Ungar, G., 1965, Effect of actinomycin D on morphine tolerance, Proc. Soc. Exp. Biol. Med. (N.Y.) 119: 381–384.Google Scholar
  12. Collier, H. O. J., 1965, A general theory of the genesis of drug dependence by induction of receptors, Nature 205: 181–182.PubMedCrossRefGoogle Scholar
  13. Collier, H. O. J., 1966, Tolerance, physical dependence and receptors: A theory of the genesis of tolerance and physical dependence through drug-induced changes in the number of receptors, in Advances in Drug Research ( N. J. Harper and A. B. Simmonds, Eds.), pp. 171–188. Academic Press, London.Google Scholar
  14. Collier, H. O. J., 1973, Pharmacological mechanisms of drug dependence, in Pharmacology and the Future of Man. Proc. 5th Int. Congr. Pharmacol., San Francisco, 1972, Vol. 1 ( J. Cochin, Ed.), pp. 65–76. Karger, Basel, Switzerland.Google Scholar
  15. Collier, H. O. J., Francis, D. L., and Schneider, C., 1972, Modification of morphine withdrawal by drugs interacting with humoral mechanisms: Some contradictions and their interpretation, Nature 237: 220–223.PubMedCrossRefGoogle Scholar
  16. Conney, A. H., 1967, Pharmacological implications of microsomal enzyme induction, Pharmacol. Rev. 19: 317–353.PubMedGoogle Scholar
  17. Cox, B. M., Ginsburg, M., and Osman, O. H., 1968, Acute tolerance to narcotic analgesic drugs in rats, Brit. J. Pharmacol. Chemotherap. 33:245–256.Google Scholar
  18. Eddy, N. B., 1953, The hot-plate method for measuring analgesic effect in mice, in Minutes of the 12th Meeting of the Committee on Drug Addiction and Narcotics, NAS-NRC,pp. 603–618. Boston, Massachusetts.Google Scholar
  19. Emmelin, N., and Murén, A., 1952, The sensitivity of submaxillary glands to chemical agents studied in cats under various conditions over long periods, Acta Physiol. Scand. 26: 221–231.PubMedCrossRefGoogle Scholar
  20. Fleming, W. W., and Trendelenburg, U., 1961, The development of supersensitivity to norepinephrine after pretreatment with reserpine, J. Pharmacol. Exp. Ther. 133: 41–51.PubMedGoogle Scholar
  21. Fraser, H. F., and Isbell, H., 1952, Comparative effects of 20 mgm. of morphine sulfate on non-addicts and former morphine addicts, J. Pharmacol. Exp. Ther. 105: 498–502.PubMedGoogle Scholar
  22. Friedman, M. J., and Jaffe, H. J., 1969, A central hypothermic response to pilocarpine in the mouse, J. Pharmacol. Exp. Ther. 167: 34–44.PubMedGoogle Scholar
  23. Friedman, M. J., Jaffe, H. J., and Sharpless, S. K., 1969, Central nervous system supersensitivity to pilocarpine after withdrawal of chronically administered scopolamine, J. Pharmacol. Exp. Ther. 167: 45–55.PubMedGoogle Scholar
  24. Gaddum, J. H., and Picarelli, A. P., 1957, Two kinds of tryptamine receptors, Brit. J. Pharmacol. Chemotherap. 12:323–328.Google Scholar
  25. Gebhart, G. F., Sherman, A., and Mitchell, C. L., 1971, The influence of learning on morphine analgesia and tolerance development in rats tested on the hot plate, Psychopharmacol. 22: 295–304.CrossRefGoogle Scholar
  26. Gianutros, G., Hynes, M. D., Puri, S. K., Drawbaugh, R. B., and Lai, H., 1974, Effect of apomorphine and nigrostriatal lesions on aggression and straital dopamine turnover during morphine withdrawal: Evidence for dopaminergic supersensitivity in protracted abstinence, Psychopharmacol 34: 37–44.CrossRefGoogle Scholar
  27. Goldstein, A., and Goldstein, D. B., 1968, Enzyme expansion theory of drug tolerance and physical dependence, in The Addictive States: Research Publications of the Association for Research in Nervous and Mental Disease, Vol. 46 ( A. Wikler, Ed.), pp. 265–267. Williams & Wilkins, Baltimore, Maryland.Google Scholar
  28. Goldstein, D. B., and Goldstein, A., 1961, Possible role of enzyme inhibition and repression in drug tolerance and addiction, Biochem. Pharmacol. 8: 48.CrossRefGoogle Scholar
  29. Gunne, L. M., 1962, Catecholamine metabolism in morphine withdrawal in the dog, Nature 195:815–816.Google Scholar
  30. Gunne, L. M., 1963, Catecholamines and 5-hydroxytryptamine in morphine tolerance and withdrawal, Acta Physiol. Scand. 58 (Suppl. 204): 1–91.Google Scholar
  31. Gunne, L. M., and Lewander, T., 1967, Long-term effects of some dependence-producing drugs on the brain monoamines, in Molecular Basis of Some Aspects of Mental Activity, Vol. 2 (0. Wallaas, Ed.), pp. 75–81. Academic Press, New York.Google Scholar
  32. Hampel, C. W., 1935, The effect of denervation on the sensitivity to adrenine of the smooth muscle in the nictitating membrane of the cat, Amer. J. Physiol. 111: 611–621.Google Scholar
  33. Hayes, R. L., and Mayer, D. J., 1978, Morphine tolerance: Is there evidence for a condition-ing model? Science 200: 343–344.Google Scholar
  34. Himmelsbach, C. K., 1941, Studies on the relation of drug addiction to the autonomic nervous system: Results of cold pressor tests, J. Pharmacol. Exp. Ther. 73: 91–97.Google Scholar
  35. Himmelsbach, C. K., 1942, Clinical studies on drug addiction: Physical dependence, with-drawal and recovery, Arch. Intern. Med. 69: 766–772.Google Scholar
  36. Himmelsbach, C. K., 1943, With reference to physical dependence, Fed. Proc. 2: 201–203.Google Scholar
  37. Jaffe, J. H., and Sharpless, S. K., 1965, The rapid development of physical dependence on barbiturates, J. Pharmacol. Exp. Ther. 150: 140–145.PubMedGoogle Scholar
  38. Jaffe, J. H., and Sharpless, S. K., 1968, Pharmacological denervation supersensitivity in the central nervous system: a theory of physical dependence, in The Addictive States: Research Publications of the Association for Research in Nervous and Mental Disease, Vol. 46 ( A Wikler, Ed.), pp. 226–243. Williams & Wilkins, Baltimore, Maryland.Google Scholar
  39. Jasinski, D. R., Martin, W. R., and Haertzen, C. A., 1967, The human pharmacology and abuse potential of N-allylnoroxymorphone (naloxone), J. Pharmacol. Exp. Ther. 157: 420–1426.PubMedGoogle Scholar
  40. Jhanneson, T., and Long, J. P., 1964, Acetylcholine in the brain of morphine tolerant and nontolerant rats, Acta Pharmacol. Toxicol. 21: 192–196.Google Scholar
  41. Kayan, S., Woods, L. A., and Mitchell, C. L., 1969, Experience as a factor in the develop-ment of tolerance to the analgesic effect of morphine, Eur. J. Pharmacol. 6: 333–339.PubMedCrossRefGoogle Scholar
  42. Kornetsky, C., and Bain, G., 1967, Single dose tolerance to morphine, The Pharmacologist 9: 219.Google Scholar
  43. Kornetsky, C., and Bain, G., 1968, Morphine: Single-dose tolerance, Science 162: 1011–1012.PubMedCrossRefGoogle Scholar
  44. Kuyer, A., and Wijsenbeek, I. A., 1913, Über Entgiftungserregung und Entgiftungshemmung, Arch. Ges. Physiol. 154: 16–38.CrossRefGoogle Scholar
  45. Lieber, C. S., and DeCarli, L. M., 1968, Ethanol oxidation by hepatic microsomes: Adaptive increase after ethanol feeding, Science 162: 917–918.PubMedCrossRefGoogle Scholar
  46. Loh, H. H., and Way, W. L., 1968, Brain serotonin turnover and tolerance development to morphine, The Pharmacologist 10: 211.Google Scholar
  47. Loh, H. H., Shen, F. H., and Way, E. L., 1969, Inhibition of morphine tolerance and physical dependence development and brain serotonin synthesis by cycloheximide, Biochem. Pharmacol. 18: 2711–2721.PubMedCrossRefGoogle Scholar
  48. Martin, W. R., 1967, Opioid antagonists, Pharmacol. Rev. 19: 463–521.PubMedGoogle Scholar
  49. Martin, W. R., 1968, A homeostatic and redundancy theory of tolerance to and dependence on narcotic analgesics, in The Addictive States: Research Publications of the Association for Research in Nervous and Mental Disease, Vol. 46 ( A. Wikler, Ed.), pp. 206–223. Williams & Wilkins, Baltimore, Maryland.Google Scholar
  50. Martin, W. R., 1970, Pharmacological redundancy as an adaptive mechanism in the central nervous system, Fed. Proc. 29: 13–18.PubMedGoogle Scholar
  51. Martin, W. R., and Eades, C. G., 1967, Pharmacological studies of spinal cord adrenergic and cholinergic mechanisms and their relation to physical dependence on morphine, Psychopharmacologie 11: 195–223.CrossRefGoogle Scholar
  52. Martin, W. R., and Jasinski, D. R., 1969, Physiological parameters of morphine dependence in man—Tolerance, early abstinence, protracted abstinence, J. Psychiat. Res. 7: 9–17.PubMedCrossRefGoogle Scholar
  53. Martin, W. R., Wikler, A., Eades, C. G., and Pescor, F. T., 1963, Tolerance to and physical dependence on morphine in rats, Psychopharmacologia 4: 247–260.PubMedCrossRefGoogle Scholar
  54. Martin, W. R., Jasinski, D. R., Sapira, J. D., Flanary, H. G., Kelly, O. A., Thompson, A. K., and Logan, C. R., 1968, The respiratory effects of morphine during a cycle of dependence, J. Pharmacol. Exp. Ther. 162: 182–189.PubMedGoogle Scholar
  55. Maynert, E. W., 1968, Catecholamine metabolism in the brain and adrenal medulla during addiction to morphine and in the early abstinence period, in The Addictive States: Research Publications of the Association for Research in Nervous and Mental Disease, Vol. 46 ( A. Wikler, Ed.), pp. 89–95. Williams & Wilkins, Baltimore, Maryland.Google Scholar
  56. Maynert, E. W., and Klingman, G. I., 1962, Tolerance to morphine. I. Effects on catecholamines in the brain and adrenal glands, J. Pharmacol. Exp. Ther. 135: 285–295.PubMedGoogle Scholar
  57. Maynert, E. W., Klingman, G. I., and Kaji, H. K., 1962, Tolerance to morphine II Lack of effects on brain 5-hydroxytryptamine and gamma-amino-butyric acid, J. Pharmacol. Exp. Ther. 135: 296–299.PubMedGoogle Scholar
  58. Nybäck, H., Borzecki, Z., and Sedvall, G., 1968, Accumulation and disappearance of catecholamines formed from tyrosine 14C in mouse brain: Effect of some psychotropic drugs, Europ. J. Pharmacol. 4: 395–403.CrossRefGoogle Scholar
  59. Paton, W. D. M., 1957, The action of morphine and related substances on contraction and on acetylcholine output of the coaxially stimulated guinea pig ileum, Brit. J. Pharmacol. Chemotherap. 12: 119–127.Google Scholar
  60. Paton, W. D. M., 1963, Cholinergic transmission and acetylcholine output, Canad. J. Biochem. Physiol. 41: 2637–2653.PubMedCrossRefGoogle Scholar
  61. Pérez-Cruet, J., 1976, Conditioning or striatal dopamine metabolism with methadone, morphine or bulbocapnine as an unconditioned stimulus, Pavlovian J. Biol. Sci. 11: 237–250.Google Scholar
  62. Puri, S. K., and Lal, H., 1973, Effect of dopaminergic stimulation or blockade on morphine-withdrawal aggression, Psychopharmacologia 32: 113–120.PubMedCrossRefGoogle Scholar
  63. Puri, S. K., Reddy, C., and Lal, H., 1973, Blockade of central dopaminergic receptors by morphine: Effect of haloperidol, apomorphine or benztropine, Res. Comm. Chem. Path. Pharmacol. 5: 389–401.Google Scholar
  64. Rosenman, S. J., and Smith, C. B., 1972, 14C-catecholamine synthesis in mouse brain during morphine withdrawal, Nature 240: 153–155.Google Scholar
  65. Sakel, M., 1930, Theorie der Sucht, Z. Ges. Neurol. Psychiat. 129: 639–646.CrossRefGoogle Scholar
  66. Sasme, H., Pérez-Cruet, J., DiChiara, G., Tagliamonte, A., Tagliamonte, P., and Gessa, G. L., 1972, Evidence that methadone blocks dopamine receptors in the brain, J. Neu rock em. 19: 1953–1957.Google Scholar
  67. Schaumann, W., 1957, Inhibition by morphine of the release of acetylcholine from the intestine of the guinea pig, Brit. J. Pharmacol. Chemotherap. 12: 115–118.Google Scholar
  68. Seevers, M. H., and Deneau, G. A., 1961, A critique of the “dual action” hypothesis of morphine physical dependence, Arch. Int. Pharmacodyn. Thérap. 140: 514–520.Google Scholar
  69. Shoham, S., and Weinstock, M., 1974, The role of supersensitivity to acetylcholine in the production of tolerance to morphine in stimulated guinea-pig ileum, Brit. J. Pharmacol. 52: 597–603.Google Scholar
  70. Shuster, L., 1961, Repression and derepression of enzyme synthesis as a possible explanation of some aspects of drug action, Nature 189: 314–315.CrossRefGoogle Scholar
  71. Siegel, S., 1975, Evidence from rats that morphine tolerance is a learned response, J. Comp. Physiol. Psychol. 89: 498–506.PubMedCrossRefGoogle Scholar
  72. Siegel, S., 1976, Morphine analgesic tolerance: its situation specificity supports a Pavlovian conditioning model, Science 193: 323–325.PubMedCrossRefGoogle Scholar
  73. Siegel, S., 1978, Morphine tolerance: Is there evidence for a conditioning model? Science 200: 344–345.PubMedCrossRefGoogle Scholar
  74. Siegel, M. R., and Sisler, H. D., 1964, Site of action of cycloheximide in cells of saccharomyces pastorianus. II. The nature of inhibition of protein synthesis in a cell free system, Biochem. Biophys. Acta 87: 83–89.PubMedGoogle Scholar
  75. Sloan, J. W., and Eisenman, A. J., 1968, Long persisting changes in catecholamine metabolism following addiction and withdrawal from morphine, in The Addictive States: Research Publications of the Association for Research in Nervous and Mental Disease, Vol. 46 ( A Wikler, Ed.), pp. 96–105. Williams & Wilkins, Baltimore, Maryland.Google Scholar
  76. Sloan, J. W., Brooks, J. W., Eisenman, A. J., and Martin, W. R., 1963, The effect of addiction to and abstinence from morphine on rat tissue catecholamine and serotonin levels, Psychopharmacologia 4: 261–270.Google Scholar
  77. Smith, C. B., Villareal, J. E., Bednarczyk, J. H., and Sheldon, M. I., 1970, Tolerance to morphine-induced increases in (“C) catecholamine synthesis in mouse brain, Science 170: 1106–1108.PubMedCrossRefGoogle Scholar
  78. Smith, C. B., Sheldon, M. I., Bednarczyk, J. H., and Villareal, J. E., 1972, Morphine-induced increases in the incorporation of 14C-tyrosine into “C-dopamine and ”Cnorepinephrine in the mouse brain: Antagonism by naloxone and tolerance, J. Pharmacol. Exp. Ther. 180: 547–557.Google Scholar
  79. Tatum, A. L., Seevers, M. H., and Collins, K. H., 1929, Morphine addiction and its physiological interpretation based on experimental evidences, J. Pharmacol. Exp. Ther. 36: 447–475.Google Scholar
  80. Way, E. L., Loh, H. H., and Shen, F. H., 1968, Morphine tolerance, physical dependence, and synthesis of brain 5-hydroxytryptamine, Science 162: 1290–1292.PubMedCrossRefGoogle Scholar
  81. Weeks, J. R., 1962, Experimental morphine addiction: Method for automatic intravenous injections in unrestrained rats, Science 138: 143.PubMedCrossRefGoogle Scholar
  82. Wikler, A., 1953, Opiate Addiction: Psychological and Neurophysiological Aspects in Relation to Clinical Problems. Charles C Thomas, Springfield, Illinois.Google Scholar
  83. Wikler, A., 1972, Theories related to physical dependence, in The Chemical and Biological Aspects of Drug Dependence ( S. J. Mulé and H. Brill, Eds.), pp. 359–377. Chemical Rubber Co. Press, Cleveland, Ohio.Google Scholar
  84. Wikler, A., and Carter, R. L., 1953, Effects of single doses of N-allynormorphine on hindlimb reflexes of chronic spinal dogs during cycles of morphine addiction, J. Pharmacol. Exp. Ther. 109: 92–101.PubMedGoogle Scholar
  85. Wikler, A., and Frank, K., 1948, Hindlimb reflexes of chronic spinal dogs during cycles of addiction to morphine and methadone, J. Pharmacol. Exp. Ther. 94: 382–400.PubMedGoogle Scholar
  86. Wikler, A., and Rayport, M., 1954, Lower limb reflexes of a chronic “spinal” man in cycles of morphine and methadone addiction, Arch. Neurol. Psychiat. (Chicago) 71: 160–170.Google Scholar
  87. Yamamoto, I., Inoki, R., Tamari, Y., and Iwatsubo, K., 1967, Inhibitory effect of 8-azaguanine on the development of tolerance in the analgesic action of morphine, Jap. J. Pharmacol. 17: 140–142.PubMedCrossRefGoogle Scholar

Copyright information

© Plenum Press, New York 1980

Authors and Affiliations

  • Abraham Wikler
    • 1
  1. 1.Department of PsychiatryUniversity of Kentucky Medical CenterLexingtonUSA

Personalised recommendations